Stereotaxis Stock Insiders

STXS -  USA Stock  

USD 1.99  0.11  5.24%

Stereotaxis employes about 130 people. The company is managed by 19 executives with total tenure of roughly 162 years, averaging almost 8.0 years of service per executive having 6.84 employees per reported executive. Discussion of Stereotaxis management performance can provide insight into the enterprise performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Stereotaxis future performance.
Additionally, take a look at World Market Map.
  
Refresh
  William Mills  Chairman
Chairman of the Board, CEO
  Paul Brathwaite  President
Vice President - Research & Development
  Susan Lanigan  President
Executive Vice President General Counsel

Stereotaxis Return on Sales

(0.1)

Share

Stereotaxis Management Team Effectiveness

Stereotaxis has return on total asset (ROA) of (13.84) % which means that it has lost $13.84 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.91) %, meaning that it created substantial loss on money invested by shareholders. Stereotaxis management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/24/2022, Return on Investment is likely to drop to -18.38. In addition to that, Return on Average Assets is likely to drop to -13.03. Stereotaxis Average Assets are relatively stable at the moment as compared to the past year. Stereotaxis reported last year Average Assets of 22.85 Million. As of 06/24/2022, Tangible Asset Value is likely to grow to about 21.5 M, while Current Assets are likely to drop slightly above 49.1 M.
As of 06/24/2022, Weighted Average Shares is likely to grow to about 70.6 M. Also, Weighted Average Shares Diluted is likely to grow to about 70.6 M

Stereotaxis Workforce Comparison

Stereotaxis is currently regarded as top stock in number of employees category among related companies. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 412. Stereotaxis totals roughly 130 in number of employees claiming about 32% of all equities under Medical Instruments & Supplies industry.

Stereotaxis Profit Margins

The company has Profit Margin (PM) of (30.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (36.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.37.

Stereotaxis Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stereotaxis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stereotaxis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Stereotaxis insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Stereotaxis Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Stereotaxis Price Series Summation is a cross summation of Stereotaxis price series and its benchmark/peer.
.

Stereotaxis Notable Stakeholders

A Stereotaxis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Stereotaxis often face trade-offs trying to please all of them. Stereotaxis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Stereotaxis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William Mills - Chairman of the Board, CEOProfile
Paul Brathwaite - Vice President - Research & DevelopmentProfile
Susan Lanigan - Executive Vice President General CounselProfile
Martin Stammer - CFO and Principal Accounting OfficerProfile
Karen Duros - Sr. VP, General Counsel and SecretaryProfile
Frank Cheng - Sr. VP of Marketing and Bus. Devel.Profile
Duane DeSisto - DirectorProfile
Ross Levin - DirectorProfile
Euan Thomson - Independent DirectorProfile
Eric Prystowsky - Independent DirectorProfile
Arun Menawat - DirectorProfile
Robert Messey - Independent DirectorProfile
Joseph Keegan - Independent DirectorProfile
Joseph Kiani - DirectorProfile
Nathan Fischel - DirectorProfile
David Benfer - Independent DirectorProfile
Fred Middleton - Independent DirectorProfile
David Fischel - DirectorProfile
David Giffin - VP of HRProfile

About Stereotaxis Management Performance

The success or failure of an entity such as Stereotaxis often depends on how effective the management is. Stereotaxis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Stereotaxis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Stereotaxis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Return on Investment(17.04) (18.38) 
Return on Average Assets(12.08) (13.03) 
Return on Average Equity(17.40) (18.77) 
Return on Invested Capital(0.23) (0.25) 
Return on Sales(0.1) (0.10) 
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. Stereotaxis operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 130 people.
The data published in Stereotaxis' official financial statements usually reflect Stereotaxis' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Stereotaxis. For example, before you start analyzing numbers published by Stereotaxis accountants, it's critical to develop an understanding of what Stereotaxis' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Stereotaxis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Stereotaxis' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Stereotaxis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stereotaxis. Please utilize our Beneish M Score to check the likelihood of Stereotaxis' management to manipulate its earnings.

Stereotaxis Workforce Analysis

Traditionally, organizations such as Stereotaxis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Stereotaxis within its industry.

Stereotaxis Manpower Efficiency

Return on Stereotaxis Manpower

Revenue Per Employee290.5 K
Revenue Per Executive1.8 M
Net Loss Per Employee53.6 K
Net Loss Per Executive634.7 K
Working Capital Per Employee7.7 K
Working Capital Per Executive52.9 K
Today, most investors in Stereotaxis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stereotaxis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's per employee growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Stereotaxis per employee as a starting point in their analysis.

Per Employee

Stereotaxis Per Employee Growth Over Time

Net Income Per Employee

(53,637.06)

Share
Stereotaxis Net Income Per Employee is relatively stable at the moment as compared to the past year. Stereotaxis reported last year Net Income Per Employee of (49,712.4)

Revenue Per Employee

290,521

Share
Stereotaxis Revenue Per Employee is relatively stable at the moment as compared to the past year. Stereotaxis reported last year Revenue Per Employee of 254,508
Additionally, take a look at World Market Map. Note that the Stereotaxis information on this page should be used as a complementary analysis to other Stereotaxis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Stereotaxis Stock analysis

When running Stereotaxis price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Stereotaxis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
156.8 M
Quarterly Revenue Growth YOY
-0.18
Return On Assets
-0.17
Return On Equity
-0.34
The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine Stereotaxis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stereotaxis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.